Viagenpumatucel-L (HS110)

Viagenpumatucel-L · Heat Biologics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Viagenpumatucel-L (HS110), covering 2023-08-23 to 2023-08-23. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1 Study of HS130 in Combination With Viagenpumatucel-L (HS110) in Patients With Solid Tumors [Phase 1]